PSIQ Profile Solutions Inc (CE)

YaFarm Technologies, Inc. (PINKSHEETS: YFRM) (YaFarm, or the Company) announced today that the Integrative Stem Cell Institute (ISCI), a premier provider of point-of-care, stem cell-based therapies, has concluded a definitive agreement with the Hospital Galenia to provide stem cell treatments at the medical center.

"We are pleased to partner with Galenia," says Dr. Juan Castillo Plaza, MD, founder of the ISCI. "The hospital has established itself as one of the premier medical facilities in Latin America. And our decision to partner with them is based on the service and care that they can give to our international patients."

Hospital Galenia, located in Cancun, is accredited by the Joint Commission (JCI) and Accreditation Canada (ACI). It is the only hospital in Mexico to have both of these prestigious accreditations. Galenia is a state of the art medical facility with a staff of highly trained and globally respected medical professionals. "The standard of care at Galenia," continues Castillo Plaza, "is second to none. From its medical services to its accommodations, Galenia is a perfect venue for the point of care therapies provided by ISCI."

In order to better serve the medical needs of its patients, the ISCI has appointed several physicians within Galenia to serve as faculty for the ISCI. The faculty provides the tremendous breadth of interdisciplinary experience and expertise that defines the ISCI. From neurologists to orthopedists, the faculty of the ISCI at Hospital Galenia provides the patient evaluation and medical oversight that is the hallmark of the ISCI's integrative approach. "With specialists on-site, ready to work with each patient," says Jose Cervera Caballos, MD, chief of radiology at Hospital Galenia and vice-chair of the ISCI Facility, "we are able to customize care for each patient. Our approach is both interdisciplinary and integrative, and based on patient care and safety."

With the combination of the proprietary protocols, Hospital Galenia facilities and its renowned faculty, the ISCI is in a unique position to advance the field of regenerative medicine with transparency, oversight and attention to safety. The result of this partnership with Hospital Galenia will be an increased access to autologous, cell-based medical neuromuscular and auto-immune disorder therapies within controlled and monitored clinical studies.

About Integrative Stem Cell Institute (ISCI) The Integrative Stem Cell Institute (ISCI) is a premier provider of point-of-care, stem cell-based therapies for patients from around the world. With a state of the art laboratory housed within the Hospital Galenia in Cancun, Mexico, the ISCI combines the most advanced scientific application of stem cells with second to none medical care within the structure of adaptive clinical trials to effective track long term outcomes and assure patient safety. More information on the Integrative Stem Cell Institute is available at www.iscelli.com

SAFE HARBOR STATEMENT

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward looking statements are subject include, but are not limited to, the effect of government regulation, competition, adequate financing, and other material risks. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance, or achievements to be materially different from the statements made herein.

Contact: The Integrative Stem Cell Institute Miranda Abrahams Miranda@iscelli.com Investor Contact Atlanta Capital Partners, LLC David Kugelman (866) 692-6847 info@atlcp.com